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Introduction
TNFRSF1A is involved in a Mendelian autosomal domi-
nant autoinflammatory disorder called TNFR-associated
periodic syndrome (TRAPS). Most TNFRSF1A mutations
are missense changes and, apart from those affecting
conserved cysteines, their deleterious effect remains often
questionable. This is especially true for the frequent
R92Q mutation, which might not be responsible for
TRAPS per se but represents a susceptibility factor to
multifactorial inflammatory disorders.
Objectives
This study investigates TRAPS pathophysiology in a
family exceptional by its size (13 members).
Methods
TNFRSF1A screening was performed by PCR-sequencing.
Comparison of the 3-dimensional structure and electro-
static properties of wild-type and mutated TNFR1 proteins
was performed by in silico homology modeling. TNFR1
expression was assessed by western blotting and ELISA in
lysates and supernatants of HEK293T cells transfected
with plasmids encoding wild-type and mutated TNFR1.
Results
A TNFRSF1A heterozygous missense mutation, R92W
(c.361C>T) perfectly segregated with typical TRAPS mani-
festations within the family (p<5.10-4), and was associated
with very high disease penetrance (0.9). Prediction of its
impact on protein structure revealed local conformational
changes and alterations of electrostatic properties. In addi-
tion, R92W leads to abrogation of the receptor shedding,
whereas TNFR1-R92Q behaves like the wild-type receptor.
Conclusion
These data demonstrate the pathogenicity of a mutation
affecting arginine 92, a residue whose involvement in
inflammatory disorders is deeply debated. Combined
with previous data on arginine 92 mutations, this study
discloses an unusual situation in which different amino
acid substitutions at the same position in the protein are
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